May 03, 2024

Cytovale's Diagnostic Test Demonstrates Strong Performance in Rapid Identification of Sepsis Risk, Peer-Review Study Confirms

Large scale study confirms Cytovale's IntelliSep test accurately predicts sepsis risk and severity, aids in appropriate triage and treatment pathways in emergency departments

Read More
November 15, 2023

Cytovale Secures $84 Million Series C to Advance Commercialization of Transformative Sepsis Diagnostic Tool

Norwest-led Financing Will Bring FDA-Cleared IntelliSep® Test to Hospitals Nationwide to Support Early Detection and Treatment of Serious Condition

Read More
August 01, 2023

Cytovale® Announces Commercial Launch of IntelliSep® Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments

Our Lady of the Lake Regional Medical Center in Baton Rouge, Louisiana, is the first to deploy IntelliSep to support early detection of sepsis in at-risk patients

Read More
May 22, 2023

Late-Breaking Data for Cytovale’s IntelliSep® Sepsis Test Further Validate its Potential to Aid in Rapid, Clinically Actionable Sepsis Diagnosis in Emergency Departments

Data presented at the 2023 American Thoracic Society International Conference also highlight the potential of the IntelliSep test to help hospitals and health systems improve quality and resource utilization. The IntelliSep test received U.S. Food and Drug Administration 510(k) clearance in December 2022 as a first-of-its-kind diagnostic for sepsis, a leading driver of death and hospitalization costs in the U.S.

Read More


Additional Publications


Additional Resources

Small Scientific Journal

Focusing Cells to Single Streams

Read More
Microsystems & Nanoengineering

Biophysical Classification of Cell Differentiation State

Read More
Nature - Scientific Reports

Introducing the Cell Mechanome

Read More
Annual Review of Biomedical Engineering

New Opportunities for Rapid Mechanical Measurement of Cells

Read More
Current Opinion in Biotechnology

Advances in high-throughput single-cell microtechnologies

Read More
Do you have an application for our technology?

Contact Us